Avatar photo

Jean Thompson

1585 Posts
OpenAI Completes Deal That Values the Company at  Billion

OpenAI Completes Deal That Values the Company at $80 Billion

OpenAI has completed a deal that values the San Francisco artificial intelligence company at $80 billion or more, nearly tripling its valuation in less than 10 months, according to three people with knowledge of the deal.The company would sell existing shares in a so-called tender offer led by the venture firm Thrive Capital, the people said. The deal lets employees cash out their shares in the company, rather than a traditional funding round that would raise money for business operations.OpenAI, which declined to comment, is now one of the world’s most valuable tech start-ups, behind ByteDance and SpaceX, according to…
Read More
The Antitrust Enforcers Aimed at Big Tech. Then Came the Backlash.

The Antitrust Enforcers Aimed at Big Tech. Then Came the Backlash.

The South Korean government unleashed a wave of panic across the internet industry: The country’s antitrust regulator said it would enact the toughest competition law outside Europe, curbing the influence of major technology companies.The Korea Fair Trade Commission, with the backing of President Yoon Suk Yeol, said in December that it planned to make a proposal modeled after the 2022 Digital Markets Act, the European Union’s landmark law to rein in American tech giants. This bill also seemed to target South Korea’s own internet conglomerates just as much as the Alphabets, Apples and Metas of the world.The commission said the…
Read More
More Young People Are on Multiple Psychiatric Drugs, Study Finds

More Young People Are on Multiple Psychiatric Drugs, Study Finds

The NewsGrowing numbers of children and adolescents are being prescribed multiple psychiatric drugs to take simultaneously, according to a new study in the state of Maryland. The phenomenon is increasing despite warnings that psychotropic drug combinations in young people have not been tested for safety or studied for their impact on the developing brain.The study, published Friday in JAMA Open Network, looked at the prescribing patterns among patients 17 or younger enrolled in Medicaid in Maryland from 2015 to 2020. In this group, there was a 9.5 percent increase in the prevalence of “polypharmacy,” which the study defined as taking…
Read More
U.S. Disrupts Hacking Operation Led by Russian Intelligence

U.S. Disrupts Hacking Operation Led by Russian Intelligence

The F.B.I., working with other countries, disrupted a Russian hacking operation that infiltrated more than 1,000 home and small-business internet routers in the United States and around the world, the Justice Department announced on Thursday.Russian intelligence, collaborating with cybercriminals, created a botnet, or a network of private computers infected with malicious software, to spy on military and security organizations and private corporations in countries like the United States.Using a court order, the F.B.I. secretly copied and deleted stolen data and malware from hacked routers. Doing this stopped Russia’s ability to use the routers without affecting how they function, officials said.…
Read More
Three Lessons From a Surprisingly Resilient Job Market

Three Lessons From a Surprisingly Resilient Job Market

The pandemic created an economic crisis unlike any recession on record. So perhaps it shouldn’t be surprising that the aftermath, too, has played out in a way that almost no economists expected.When unemployment soared in the first weeks of the pandemic, many feared a repeat of the long, slow rebound from the Great Recession: years of joblessness that left many workers permanently scarred. Instead, the recovery in the labor market has been, by many measures, the strongest on record.In early 2021, some economists foresaw a surge in inflation. Others were skeptical: Similar predictions in recent years — in some cases…
Read More
US Agencies Start Inquiry Into Generic Drug Shortages

US Agencies Start Inquiry Into Generic Drug Shortages

The Federal Trade Commission and the Department of Health and Human Services said on Wednesday that they would examine the causes of generic drug shortages and the practices of “powerful middlemen” that are involved in the supply chain.The federal agencies’ inquiry is aimed at the group purchasing organizations and drug distributors that have been in the spotlight in recent months as drug shortages reached a 10-year peak. The agencies want to examine the companies’ influence on how the drugs are sold to hospitals and other health facilities, assessing whether the middlemen put pressure on pricing and manufacturing that led to…
Read More